[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Non-invasive DNA Prenatal Testing Supply, Demand and Key Producers, 2023-2029

July 2023 | 122 pages | ID: G51A0E093C8BEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Non-invasive DNA Prenatal Testing market size is expected to reach $ 10360 million by 2029, rising at a market growth of 11.5% CAGR during the forecast period (2023-2029).

Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.

This report studies the global Non-invasive DNA Prenatal Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Non-invasive DNA Prenatal Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-invasive DNA Prenatal Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Non-invasive DNA Prenatal Testing total market, 2018-2029, (USD Million)

Global Non-invasive DNA Prenatal Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Non-invasive DNA Prenatal Testing total market, key domestic companies and share, (USD Million)

Global Non-invasive DNA Prenatal Testing revenue by player and market share 2018-2023, (USD Million)

Global Non-invasive DNA Prenatal Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Non-invasive DNA Prenatal Testing total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Non-invasive DNA Prenatal Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx and Agilent Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-invasive DNA Prenatal Testing market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Non-invasive DNA Prenatal Testing Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Non-invasive DNA Prenatal Testing Market, Segmentation by Type
  • Equipment
  • Consumables
Global Non-invasive DNA Prenatal Testing Market, Segmentation by Application
  • Hospital
  • Clinic
  • Other
Companies Profiled:
  • Illumina
  • Roche
  • Natera
  • Thermo Fisher Scientific
  • F. Hoffman-La Roche
  • Pacific Biosciences Of California
  • Perkinelmer
  • LifeCodexx
  • Agilent Technologies
  • Labcorp
  • Mutiplicon
  • Premaitha Health
  • Beijing BGI
  • Berry Genomics
  • Darui Biological
Key Questions Answered

1. How big is the global Non-invasive DNA Prenatal Testing market?

2. What is the demand of the global Non-invasive DNA Prenatal Testing market?

3. What is the year over year growth of the global Non-invasive DNA Prenatal Testing market?

4. What is the total value of the global Non-invasive DNA Prenatal Testing market?

5. Who are the major players in the global Non-invasive DNA Prenatal Testing market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Non-invasive DNA Prenatal Testing Introduction
1.2 World Non-invasive DNA Prenatal Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Non-invasive DNA Prenatal Testing Total Market by Region (by Headquarter Location)
  1.3.1 World Non-invasive DNA Prenatal Testing Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Non-invasive DNA Prenatal Testing Market Size (2018-2029)
  1.3.3 China Non-invasive DNA Prenatal Testing Market Size (2018-2029)
  1.3.4 Europe Non-invasive DNA Prenatal Testing Market Size (2018-2029)
  1.3.5 Japan Non-invasive DNA Prenatal Testing Market Size (2018-2029)
  1.3.6 South Korea Non-invasive DNA Prenatal Testing Market Size (2018-2029)
  1.3.7 ASEAN Non-invasive DNA Prenatal Testing Market Size (2018-2029)
  1.3.8 India Non-invasive DNA Prenatal Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Non-invasive DNA Prenatal Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Non-invasive DNA Prenatal Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.2 World Non-invasive DNA Prenatal Testing Consumption Value by Region
  2.2.1 World Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2023)
  2.2.2 World Non-invasive DNA Prenatal Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.4 China Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.5 Europe Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.6 Japan Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.7 South Korea Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.8 ASEAN Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)
2.9 India Non-invasive DNA Prenatal Testing Consumption Value (2018-2029)

3 WORLD NON-INVASIVE DNA PRENATAL TESTING COMPANIES COMPETITIVE ANALYSIS

3.1 World Non-invasive DNA Prenatal Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Non-invasive DNA Prenatal Testing Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Non-invasive DNA Prenatal Testing in 2022
  3.2.3 Global Concentration Ratios (CR8) for Non-invasive DNA Prenatal Testing in 2022
3.3 Non-invasive DNA Prenatal Testing Company Evaluation Quadrant
3.4 Non-invasive DNA Prenatal Testing Market: Overall Company Footprint Analysis
  3.4.1 Non-invasive DNA Prenatal Testing Market: Region Footprint
  3.4.2 Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
  3.4.3 Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Non-invasive DNA Prenatal Testing Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Non-invasive DNA Prenatal Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Non-invasive DNA Prenatal Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Non-invasive DNA Prenatal Testing Consumption Value Comparison
  4.2.1 United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Non-invasive DNA Prenatal Testing Companies and Market Share, 2018-2023
  4.3.1 United States Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Non-invasive DNA Prenatal Testing Revenue, (2018-2023)
4.4 China Based Companies Non-invasive DNA Prenatal Testing Revenue and Market Share, 2018-2023
  4.4.1 China Based Non-invasive DNA Prenatal Testing Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Non-invasive DNA Prenatal Testing Revenue, (2018-2023)
4.5 Rest of World Based Non-invasive DNA Prenatal Testing Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Equipment
  5.2.2 Consumables
5.3 Market Segment by Type
  5.3.1 World Non-invasive DNA Prenatal Testing Market Size by Type (2018-2023)
  5.3.2 World Non-invasive DNA Prenatal Testing Market Size by Type (2024-2029)
  5.3.3 World Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Non-invasive DNA Prenatal Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Non-invasive DNA Prenatal Testing Market Size by Application (2018-2023)
  6.3.2 World Non-invasive DNA Prenatal Testing Market Size by Application (2024-2029)
  6.3.3 World Non-invasive DNA Prenatal Testing Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Illumina
  7.1.1 Illumina Details
  7.1.2 Illumina Major Business
  7.1.3 Illumina Non-invasive DNA Prenatal Testing Product and Services
  7.1.4 Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Illumina Recent Developments/Updates
  7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 Roche
  7.2.1 Roche Details
  7.2.2 Roche Major Business
  7.2.3 Roche Non-invasive DNA Prenatal Testing Product and Services
  7.2.4 Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Roche Recent Developments/Updates
  7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Natera
  7.3.1 Natera Details
  7.3.2 Natera Major Business
  7.3.3 Natera Non-invasive DNA Prenatal Testing Product and Services
  7.3.4 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Natera Recent Developments/Updates
  7.3.6 Natera Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
  7.4.1 Thermo Fisher Scientific Details
  7.4.2 Thermo Fisher Scientific Major Business
  7.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Services
  7.4.4 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Thermo Fisher Scientific Recent Developments/Updates
  7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 F. Hoffman-La Roche
  7.5.1 F. Hoffman-La Roche Details
  7.5.2 F. Hoffman-La Roche Major Business
  7.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Services
  7.5.4 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 F. Hoffman-La Roche Recent Developments/Updates
  7.5.6 F. Hoffman-La Roche Competitive Strengths & Weaknesses
7.6 Pacific Biosciences Of California
  7.6.1 Pacific Biosciences Of California Details
  7.6.2 Pacific Biosciences Of California Major Business
  7.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Services
  7.6.4 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Pacific Biosciences Of California Recent Developments/Updates
  7.6.6 Pacific Biosciences Of California Competitive Strengths & Weaknesses
7.7 Perkinelmer
  7.7.1 Perkinelmer Details
  7.7.2 Perkinelmer Major Business
  7.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Product and Services
  7.7.4 Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Perkinelmer Recent Developments/Updates
  7.7.6 Perkinelmer Competitive Strengths & Weaknesses
7.8 LifeCodexx
  7.8.1 LifeCodexx Details
  7.8.2 LifeCodexx Major Business
  7.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Product and Services
  7.8.4 LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 LifeCodexx Recent Developments/Updates
  7.8.6 LifeCodexx Competitive Strengths & Weaknesses
7.9 Agilent Technologies
  7.9.1 Agilent Technologies Details
  7.9.2 Agilent Technologies Major Business
  7.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Product and Services
  7.9.4 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Agilent Technologies Recent Developments/Updates
  7.9.6 Agilent Technologies Competitive Strengths & Weaknesses
7.10 Labcorp
  7.10.1 Labcorp Details
  7.10.2 Labcorp Major Business
  7.10.3 Labcorp Non-invasive DNA Prenatal Testing Product and Services
  7.10.4 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Labcorp Recent Developments/Updates
  7.10.6 Labcorp Competitive Strengths & Weaknesses
7.11 Mutiplicon
  7.11.1 Mutiplicon Details
  7.11.2 Mutiplicon Major Business
  7.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Product and Services
  7.11.4 Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Mutiplicon Recent Developments/Updates
  7.11.6 Mutiplicon Competitive Strengths & Weaknesses
7.12 Premaitha Health
  7.12.1 Premaitha Health Details
  7.12.2 Premaitha Health Major Business
  7.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Product and Services
  7.12.4 Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Premaitha Health Recent Developments/Updates
  7.12.6 Premaitha Health Competitive Strengths & Weaknesses
7.13 Beijing BGI
  7.13.1 Beijing BGI Details
  7.13.2 Beijing BGI Major Business
  7.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Product and Services
  7.13.4 Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Beijing BGI Recent Developments/Updates
  7.13.6 Beijing BGI Competitive Strengths & Weaknesses
7.14 Berry Genomics
  7.14.1 Berry Genomics Details
  7.14.2 Berry Genomics Major Business
  7.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Product and Services
  7.14.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Berry Genomics Recent Developments/Updates
  7.14.6 Berry Genomics Competitive Strengths & Weaknesses
7.15 Darui Biological
  7.15.1 Darui Biological Details
  7.15.2 Darui Biological Major Business
  7.15.3 Darui Biological Non-invasive DNA Prenatal Testing Product and Services
  7.15.4 Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Darui Biological Recent Developments/Updates
  7.15.6 Darui Biological Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Non-invasive DNA Prenatal Testing Industry Chain
8.2 Non-invasive DNA Prenatal Testing Upstream Analysis
8.3 Non-invasive DNA Prenatal Testing Midstream Analysis
8.4 Non-invasive DNA Prenatal Testing Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Non-invasive DNA Prenatal Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Non-invasive DNA Prenatal Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Non-invasive DNA Prenatal Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-invasive DNA Prenatal Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Non-invasive DNA Prenatal Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Non-invasive DNA Prenatal Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Non-invasive DNA Prenatal Testing Players in 2022
Table 12. World Non-invasive DNA Prenatal Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Non-invasive DNA Prenatal Testing Company Evaluation Quadrant
Table 14. Head Office of Key Non-invasive DNA Prenatal Testing Player
Table 15. Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
Table 16. Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
Table 17. Non-invasive DNA Prenatal Testing Mergers & Acquisitions Activity
Table 18. United States VS China Non-invasive DNA Prenatal Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Non-invasive DNA Prenatal Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-invasive DNA Prenatal Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2018-2023)
Table 23. China Based Non-invasive DNA Prenatal Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-invasive DNA Prenatal Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Non-invasive DNA Prenatal Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Non-invasive DNA Prenatal Testing Revenue Market Share (2018-2023)
Table 29. World Non-invasive DNA Prenatal Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Non-invasive DNA Prenatal Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Non-invasive DNA Prenatal Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Non-invasive DNA Prenatal Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Non-invasive DNA Prenatal Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Non-invasive DNA Prenatal Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Non-invasive DNA Prenatal Testing Product and Services
Table 38. Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. Roche Basic Information, Area Served and Competitors
Table 42. Roche Major Business
Table 43. Roche Non-invasive DNA Prenatal Testing Product and Services
Table 44. Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Natera Basic Information, Area Served and Competitors
Table 48. Natera Major Business
Table 49. Natera Non-invasive DNA Prenatal Testing Product and Services
Table 50. Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Natera Recent Developments/Updates
Table 52. Natera Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Services
Table 56. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. F. Hoffman-La Roche Basic Information, Area Served and Competitors
Table 60. F. Hoffman-La Roche Major Business
Table 61. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Services
Table 62. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. F. Hoffman-La Roche Recent Developments/Updates
Table 64. F. Hoffman-La Roche Competitive Strengths & Weaknesses
Table 65. Pacific Biosciences Of California Basic Information, Area Served and Competitors
Table 66. Pacific Biosciences Of California Major Business
Table 67. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Services
Table 68. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pacific Biosciences Of California Recent Developments/Updates
Table 70. Pacific Biosciences Of California Competitive Strengths & Weaknesses
Table 71. Perkinelmer Basic Information, Area Served and Competitors
Table 72. Perkinelmer Major Business
Table 73. Perkinelmer Non-invasive DNA Prenatal Testing Product and Services
Table 74. Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Perkinelmer Recent Developments/Updates
Table 76. Perkinelmer Competitive Strengths & Weaknesses
Table 77. LifeCodexx Basic Information, Area Served and Competitors
Table 78. LifeCodexx Major Business
Table 79. LifeCodexx Non-invasive DNA Prenatal Testing Product and Services
Table 80. LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. LifeCodexx Recent Developments/Updates
Table 82. LifeCodexx Competitive Strengths & Weaknesses
Table 83. Agilent Technologies Basic Information, Area Served and Competitors
Table 84. Agilent Technologies Major Business
Table 85. Agilent Technologies Non-invasive DNA Prenatal Testing Product and Services
Table 86. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Agilent Technologies Recent Developments/Updates
Table 88. Agilent Technologies Competitive Strengths & Weaknesses
Table 89. Labcorp Basic Information, Area Served and Competitors
Table 90. Labcorp Major Business
Table 91. Labcorp Non-invasive DNA Prenatal Testing Product and Services
Table 92. Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Labcorp Recent Developments/Updates
Table 94. Labcorp Competitive Strengths & Weaknesses
Table 95. Mutiplicon Basic Information, Area Served and Competitors
Table 96. Mutiplicon Major Business
Table 97. Mutiplicon Non-invasive DNA Prenatal Testing Product and Services
Table 98. Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Mutiplicon Recent Developments/Updates
Table 100. Mutiplicon Competitive Strengths & Weaknesses
Table 101. Premaitha Health Basic Information, Area Served and Competitors
Table 102. Premaitha Health Major Business
Table 103. Premaitha Health Non-invasive DNA Prenatal Testing Product and Services
Table 104. Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Premaitha Health Recent Developments/Updates
Table 106. Premaitha Health Competitive Strengths & Weaknesses
Table 107. Beijing BGI Basic Information, Area Served and Competitors
Table 108. Beijing BGI Major Business
Table 109. Beijing BGI Non-invasive DNA Prenatal Testing Product and Services
Table 110. Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Beijing BGI Recent Developments/Updates
Table 112. Beijing BGI Competitive Strengths & Weaknesses
Table 113. Berry Genomics Basic Information, Area Served and Competitors
Table 114. Berry Genomics Major Business
Table 115. Berry Genomics Non-invasive DNA Prenatal Testing Product and Services
Table 116. Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Berry Genomics Recent Developments/Updates
Table 118. Darui Biological Basic Information, Area Served and Competitors
Table 119. Darui Biological Major Business
Table 120. Darui Biological Non-invasive DNA Prenatal Testing Product and Services
Table 121. Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Non-invasive DNA Prenatal Testing Upstream (Raw Materials)
Table 123. Non-invasive DNA Prenatal Testing Typical Customers

LIST OF FIGURES

Figure 1. Non-invasive DNA Prenatal Testing Picture
Figure 2. World Non-invasive DNA Prenatal Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-invasive DNA Prenatal Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Non-invasive DNA Prenatal Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Non-invasive DNA Prenatal Testing Revenue (2018-2029) & (USD Million)
Figure 13. Non-invasive DNA Prenatal Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Non-invasive DNA Prenatal Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-invasive DNA Prenatal Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-invasive DNA Prenatal Testing Markets in 2022
Figure 27. United States VS China: Non-invasive DNA Prenatal Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-invasive DNA Prenatal Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Non-invasive DNA Prenatal Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2022
Figure 31. Equipment
Figure 32. Consumables
Figure 33. World Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Non-invasive DNA Prenatal Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Other
Figure 39. Non-invasive DNA Prenatal Testing Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source


More Publications